Baska ® Mask Versus Endotracheal Tube in Laparoscopic Cholecystectomy

Sponsor
University of Malaya (Other)
Overall Status
Completed
CT.gov ID
NCT03045835
Collaborator
(none)
60
1
2
25
2.4

Study Details

Study Description

Brief Summary

Baska mask is a new novel supraglottic airway device with many salient features. The investigators aim to determine the benefit of BASKA mask as an effective airway device for laparoscopic surgery, and whether it can even substitute endotracheal intubation, in order to smoothen the surgery and anaesthesia process as well as reduce perioperative complications.

Condition or Disease Intervention/Treatment Phase
  • Device: BASKA mask
  • Device: Endotracheal intubation
N/A

Detailed Description

Patient's satisfaction and smooth process is crucial for perioperative care.Conduct of Anaesthesia including choice of airway devices play an important role. Endotracheal intubation has long been regarded as the technique of choice for airway management in laparoscopic surgery. However, there is currently an emerging interest in laryngeal mask as the substitute for endotracheal tube in laparoscopic surgery.

The increased abdominal pressure secondary to gas insufflation in Laparoscopic surgery demands a good supraglottic airway device with features of good seal, aspiration prevention and effective ventilation.

Few studies have evaluated the performance Baska® Mask for various type of surgery and had obtained high "first-attempt" success rate, easy insertion and a good oropharyngeal leak pressure above 30cmH2O with low complications such as sorethroat, dysphonia and dysphagia.

However, study regarding comparison of Baska® mask with endotracheal tube has not been carried out before. Therefore, the investigators would like to evaluate this novel device in comparison with endotracheal tube for laparoscopic surgery in our centre.

This will be a prospective randomized controlled study in University Malaya Medical Centre to compare Baska® mask with the conventional laryngoscope-guided endotracheal intubation for laparoscopic surgeries.

The investigators would like to study the efficacy of this device in term of : time to effective airway insertion, efficacy of airway seal, post-operation device of complications.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Baska ® Mask Versus Endotracheal Tube in Laparoscopic Cholecystectomy : A Prospective Randomized Trial
Actual Study Start Date :
Mar 1, 2017
Actual Primary Completion Date :
Aug 31, 2018
Actual Study Completion Date :
Mar 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: BASKA mask

Selection of size : size 3 (30-50kg), size 4 (50-70kg), size 5 (70-100kg)

Device: BASKA mask
Baska mask will be inserted during induction of anaesthesia and once patient is in an adequate anaesthetic depth

Active Comparator: Endotracheal intubation

Selection of size : ID 7.0-7.5mm (women), ID 7.5-8.0mm (men)

Device: Endotracheal intubation
Endotracheal intubation will be carried out during induction of anaesthesia and once patient is in an adequate anaesthetic depth

Outcome Measures

Primary Outcome Measures

  1. Time to effective airway insertion [1 hour]

    defined as time from picking up the airway device (either BASKA mask or Endotracheal tube), insertion and until occurrence of the first square-waveform capnogram

Secondary Outcome Measures

  1. Numbers of attempt of airway device insertion and Ease of insertion [1 hour]

    defined as: 1 - first attempt easy, smooth insertion; 2 - second attempt, insertion with resistance; 3 - three attempts, insertion with difficulty; 4 -failed insertion of the SGAs and need to crossover to ETT group

  2. Gastric distension scoring by surgeon [during operative duration]

    on a visual analogue scale 0-10 (Figure 2), where 0 = empty stomach, and 10 = heavy distension that interfered with surgical exposure at a) entry of the laparoscope following peritoneal insufflation and b) immediately before removal of the laparoscope at the end of the surgical procedure

  3. Post operation incidence of complications [from the induction of anaesthesia, until at the postanaesthetic care unit (PACU), assessed up to 24 hours]

    patients are assessed for the incidence of sore throat, airway trauma (lip, tongue, teeth, blood-staining on device), nausea, vomiting, airway spasm, aspiration, emergence cough

  4. Hemodynamic changes [after induction of anaesthesia at 1, 2, 3,4,5,10,20,30 minutes; then post extubation at 1 ,2,3,4,5 minutes]

    Blood pressure and Heart rate

Other Outcome Measures

  1. oropharyngeal leak pressure (OPL) of the device during operation [during operative duration]

    the above pressure is measured by performing the maneuver: the expiratory valve of the anaesthetic machine is closed and with a fixed gas flow of 3 L/min, the airway pressure at which equilibrium is reached is recorded. Maximal allowable airway pressure is 40 cm H2O [ OLP is measured at following timeframe - T1: immediately post intubation; T2 : before CO2 insufflation; T3 : after CO2 insufflation; T4 and beyond : each change of position as required during operation (eg. Trendelenburg, reverse Trendelenburg, left tilt)

  2. peak airway pressure of the device during operation [during operative duration]

    the above pressure is recorded from the anaesthetic machine at following timeframe - T1: immediately post intubation; T2 : before CO2 insufflation; T3 : after CO2 insufflation; T4 and beyond : each change of position as required during operation (eg. Trendelenburg, reverse Trendelenburg, left tilt)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 to 75 years old

  • American Society of Anesthesiologists (ASA) physical status I and II BMI ≤ 35

  • Laparoscopic cholecystectomy only

Exclusion Criteria:
  • Known gastroesophageal reflux

  • History of difficult intubation or difficult anaesthesia

  • Features of facial, laryngeal and pharyngeal anatomy problem

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Malaya Medical Centre Petaling Jaya Selangor Malaysia 59100

Sponsors and Collaborators

  • University of Malaya

Investigators

  • Principal Investigator: CHING CHOE NG, MMED(ANAES), UNIVERSITY OF MALAYA MEDICAL CENTRE

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ng Ching Choe, MD, MMED (Anaes), University of Malaya
ClinicalTrials.gov Identifier:
NCT03045835
Other Study ID Numbers:
  • MREC ID NO: 201713-4728
First Posted:
Feb 8, 2017
Last Update Posted:
Jul 7, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ng Ching Choe, MD, MMED (Anaes), University of Malaya

Study Results

No Results Posted as of Jul 7, 2020